Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
One More Child Sounds Alarm on Human Trafficking During “See it. Say it. Stop it.” Event at Texas A&M University
-
TWC Enterprises Limited Announces 2023 Year End Results and Increase in Eligible Dividend
-
CN Reaches New Tentative Collective Agreement with United Steelworkers
-
Brookfield Property Partners Completes 2023 Annual Filings
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Kirby McInerney LLP Reminds Innodata, Inc. Investors of Class Action Filing and Encourages Investors to Contact the Firm
-
Kirby McInerney LLP Reminds Sunnova Energy International Inc. (NOVA) Investors of Class Action Filing and Encourages Investors to Contact the Firm
-
Kirby McInerney LLP Reminds Dick’s Sporting Goods, Inc. (DKS) Investors of Class Action Filing and Encourages Investors to Contact the Firm
-
Kirby McInerney LLP is Investigating Shareholder Claims Against Methanex Corp. (MEOH)
-
Readout of SBA Administrator Guzman’s Attendance at White House Roundtable on Increasing Capital Access for Tribal Nations
-
Pimco Closed-End Funds Declare Monthly Common Share Distributions
-
ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference
-
CN Reaches New Tentative Collective Agreement with United Steelworkers
-
Brookfield Property Partners Completes 2023 Annual Filings
-
Fairfax Announces Quarterly Dividend on Series C, D, E, F, G, H, I, J, K and M Preferred Shares and Quarterly Dividend Rate for Series D, F, H and J Preferred Shares
-
Farmer Brothers Names Matthew Swenson Vice President of Coffee Operations
-
Iovance Biotherapeutics to Present at Upcoming Conferences
-
LeMaitre to Participate at Upcoming Investor Conferences in March
-
Madison Covered Call and Equity Strategy Fund (MCN) Declares Quarterly Dividend
-
Guggenheim Investments Announces March 2024 Closed-End Fund Distributions
-
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Remuneration of Directors and Executives by distribution of Millicom (Tigo) shares
-
EKU Pre-Med Student Aspires to Serve Eastern Kentucky Community
-
ARMOUR Residential REIT, Inc. Announces Updated Estimated Book Value
-
ARMOUR Residential REIT, Inc. Files Form 12b-25 With the Securities and Exchange Commission
-
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Mega Matrix Announces Inspiring Operating Metrics for the First Two Months of 2024
-
Power Solutions International Appoints Randall Lehner as General Counsel
-
Molecular Partners Announces Dismissal of Class Action Lawsuit
-
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
StoneX Group Inc. Announces Closing of $550 Million of Senior Secured Notes due 2031
-
Brookfield Renewable Completes Annual Filings
-
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Nasdaq Chief Financial Officer Sarah Youngwood to Present at the Morgan Stanley Technology, Media & Telecom Conference
-
Nasdaq Chief Financial Officer Sarah Youngwood to Present at the Morgan Stanley Technology, Media & Telecom Conference
-
Cipher Mining Announces February 2024 Operational Update
-
Trio Petroleum Announces Notice of Noncompliance with NYSE American Listing Standards
-
Magic Empire Global Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024
-
NurExone Presenting Novel Regulatory Pathways for Exosomes Therapies at Global Summit
-
Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Silvercrest Asset Management (SAMG) to Announce Fourth Quarter and Year-End 2023 Results and Host Investor Conference Call
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations
-
Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations
-
Pennant Acquires Two Senior Living Communities in Utah
-
ROSEN, A LEADING LAW FIRM, Encourages Mobileye Global Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MBLY
-
MSS DEADLINE MONDAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Maison Solutions Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action – MSS
